000 | 01655 a2200433 4500 | ||
---|---|---|---|
005 | 20250511201646.0 | ||
264 | 0 | _c19910801 | |
008 | 199108s 0 0 eng d | ||
022 | _a0022-1007 | ||
024 | 7 |
_a10.1084/jem.174.1.35 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLublin, D M | |
245 | 0 | 0 |
_aPhospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage. _h[electronic resource] |
260 |
_bThe Journal of experimental medicine _cJul 1991 |
||
300 |
_a35-44 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAntigens, CD |
650 | 0 | 4 | _aCD55 Antigens |
650 | 0 | 4 |
_aCell Membrane _xphysiology |
650 | 0 | 4 | _aCell Survival |
650 | 0 | 4 |
_aComplement C3 _xphysiology |
650 | 0 | 4 |
_aComplement Inactivator Proteins _xphysiology |
650 | 0 | 4 |
_aComplement System Proteins _xphysiology |
650 | 0 | 4 |
_aDNA _xgenetics |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aGlycolipids _xphysiology |
650 | 0 | 4 | _aGlycosylphosphatidylinositols |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aMembrane Cofactor Protein |
650 | 0 | 4 |
_aMembrane Glycoproteins _xgenetics |
650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
650 | 0 | 4 |
_aPhosphatidylinositols _xphysiology |
650 | 0 | 4 | _aTransfection |
700 | 1 | _aCoyne, K E | |
773 | 0 |
_tThe Journal of experimental medicine _gvol. 174 _gno. 1 _gp. 35-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1084/jem.174.1.35 _zAvailable from publisher's website |
999 |
_c1717967 _d1717967 |